Targeting pathological B cell receptor signalling in lymphoid malignancies
Top Cited Papers
- 1 March 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Drug Discovery
- Vol. 12 (3), 229-243
- https://doi.org/10.1038/nrd3937
Abstract
No abstract availableKeywords
This publication has 130 references indexed in Scilit:
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Monophosphorylation of CD79a and CD79b ITAM Motifs Initiates a SHIP-1 Phosphatase-Mediated Inhibitory Signaling Cascade Required for B Cell AnergyImmunity, 2011
- Receptors, subcellular compartments and the regulation of peripheral B cell responses: The illuminating state of anergyMolecular Immunology, 2011
- Selective Utilization of Toll-like Receptor and MyD88 Signaling in B Cells for Enhancement of the Antiviral Germinal Center ResponseImmunity, 2011
- Origin of Chromosomal Translocations in Lymphoid CancerCell, 2010
- Suppression of Phosphatidylinositol 3,4,5-Trisphosphate Production Is a Key Determinant of B Cell AnergyImmunity, 2009
- PI3 Kinase Signals BCR-Dependent Mature B Cell SurvivalCell, 2009
- Antigen receptor signalling: a distinctive role for the p110δ isoform of PI3KTrends in Immunology, 2007
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Defective B cell development and function in Btk-deficient miceImmunity, 1995